NewSouth Innovations has a team of highly qualified professionals with decades of combined commercial experience in a broad range of fields including the pharmaceutical, biotechnology and engineering industries, together with extensive experience in research commercialisation and the corporate world.

This expertise, coupled with the calibre of research at UNSW – a top 4 in Australia research intensive university - provides an unparalleled advantage in the transfer of technologies to the marketplace.

NewSouth Innovations has a Board of Directors. Mr Mark Bennett is the Chief Executive Officer.

NSi’s organisational chart

In addition to NSi's own staff the following companies provide services to NSi in the area of intellectual property and legal advice:

BwiseIP http://www.bwiseip.com

Spruson & Ferguson http://www.sprusons.com.au

Griffith Hack http://www.griffithhack.com.au

BwiseIP is a consulting company that meets the intellectual property management requirements of R&D start up entities, technology companies, research centres and universities. BwiseIP implements IP management and conducts commercialisation of IP from a business perspective using its combination of technology based, market based and business based management skills. The result is an IP management function that augments the business objectives. BwiseIP focuses on Business Integrated Intellectual Property Management, because this leads to greater scope for return on investment.

BwiseIP specialises in managing the intellectual backbone of the commercialisation process, that is: granted patents, patent applications, inventions, trade secrets, know how; and extracting the optimal value from the IP.

The long term projects for BwiseIP at NSi include establishing IP management infrastructure, managing strategic IP protection and conducting focussed IP mapping/landscaping exercises. Shorter term IP projects include IP evaluations, IP audits, working with NSi to extract value from the IP and managing specific commercialisation projects.

Mr Mark Bennett, B.Sc., Dip Nat. Res (UNE), Chief Executive Officer

Mark Bennett has been the CEO of NSi since 2006 and has over 25 years experience in research commercialisation in the private and public sectors. For the last eight years Mark has worked at the interface between the academic world, industry and the investment community and prior to that was a successful CEO within the private sector, working for a subsidiaries of the Cagene Pacific (Florigene), an ag-biotech, and for the Forbio Group of companies.

Mark “jumped the fence” to the Business Liaison Office of the University of Sydney. While there, he formed a specialised business unit responsible for spin off company formation, management and investment capital raising. This resulted in the formation of over 16 new companies. He was appointed Acting Director of the Business Liaison Office, at the University of Sydney before joining NSi.

Mark has extensive experience as a company director and chairman. He is currently on the Boards of Hepatocell Therapeutics Pty Ltd., Qucor Pty Ltd., Acyte Pty Ltd., and Cystemix Pty Ltd. among others.

Mark remains firmly hooked by and committed to the industry. He spends a good part of his working life managing expectations while striving for that common goal of seeing university intellectual property successfully commercialised.

email: m.bennett@nsinnovations.com.au
phone: +61 (2) 9385 6527
fax: +61 (2) 9385 6502

Executive Officer:

Ilona Sheridan
email: i.sheridan@nsinnovations.com.au
phone: +61 (2) 9385 6505
fax: +61 (2) 9385 6600